INTERCEPT PHARMACEUTICALS, INC. Annual Operating Income (Loss) in USD from 2014 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Intercept Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2022.
  • Intercept Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$4.62M, a 54.5% increase year-over-year.
  • Intercept Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$62.3M, a 21.3% increase year-over-year.
  • Intercept Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$68.2M, a 32.1% increase from 2021.
  • Intercept Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$100M, a 56.3% increase from 2020.
  • Intercept Pharmaceuticals, Inc. annual Operating Income (Loss) for 2020 was -$230M, a 26.5% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$68.2M +$32.2M +32.1% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-02
2021 -$100M +$129M +56.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
2020 -$230M +$82.7M +26.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-02
2019 -$312M -$26.9M -9.44% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-02
2018 -$285M +$50.1M +14.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$336M +$66.9M +16.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-25
2016 -$403M -$173M -75.7% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 -$229M -$116M -102% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-28
2014 -$113M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.